Custom Surgical is a technology company.
Custom Surgical has raised $600K across 1 funding round.
Custom Surgical has raised $600K in total across 1 funding round.
Custom Surgical has raised $600K in total across 1 funding round.
Custom Surgical's investors include Aniq Kassam, Luminate Accelerator.
Custom Surgical is a medtech startup founded in 2019 that modernizes ophthalmology by digitizing surgical microscopes and slit-lamps using affordable, smartphone-based optical systems like MicroREC, paired with a cloud-based data management platform for storing, sharing, and analyzing clinical images and videos[1][2][3][4][5]. It serves eye care professionals worldwide—ophthalmologists, surgeons, and clinics—solving the problem of expensive, brand-specific recording tools that over 80% of microscopes lack, enabling high-quality capture without engineers, early pathology detection via AI and AR apps, surgeon training, and reduced avoidable blindness affecting 43 million people globally[2][3][4][5]. The company has achieved strong growth, selling devices in 61+ countries, securing licensing deals with major manufacturers, and seeing its software adopted by over 3,000 specialists with rapid data acquisition[3][4].
Custom Surgical was established in 2019 in Munich, Germany, by co-founders Federico Acosta (CEO) and Fernando Benito (CTO), who identified gaps in microscope digitization during their work in ophthalmology[1][3][4]. Insights from clinical needs—such as the inability to easily record procedures for analysis, training, or early diagnosis—led to the development of MicroREC, a smartphone-compatible optical adapter, alongside a software platform for automatic patient screening[1][2][4]. Early traction came quickly through distributor networks and partnerships, expanding to 61 countries and licensing with microscope makers, while the team grew to include experts like Marc Frigola (Head of Sales) and regional directors[3][4].
Custom Surgical rides the wave of medtech digitization and AI-driven diagnostics in ophthalmology, addressing a market where vision impairment could double to 86 million blind and 600 million impaired by 2050 due to late detections[4]. Timing aligns with smartphone ubiquity and cloud adoption, making high-end microscope features accessible in underserved regions and reducing barriers in diverse clinics[2][3][5]. Favorable forces include rising demand for telemedicine, remote training post-COVID, and partnerships with manufacturers, positioning it to influence ecosystem-wide shifts toward affordable, data-rich eye care and preventing avoidable blindness[1][4][7].
Custom Surgical is poised for expansion through deeper AI integrations for real-time diagnostics, broader AR training platforms, and scaling licensing deals amid growing global eye health needs[1][2][4]. Trends like AI pathology screening and mobile medtech will accelerate adoption, potentially halving early-detection gaps in high-burden areas. Its influence may evolve from hardware innovator to full-stack ophthalmology AI leader, further democratizing tools and amplifying impact on the 300 million with vision impairments[3][4]. This builds on its core mission: turning smartphones into lifesaving microscope extensions.
Custom Surgical has raised $600K across 1 funding round. Most recently, it raised $600K Seed in October 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2022 | $600K Seed | Aniq Kassam, Luminate Accelerator |